Sec Form 4 Filing - ALBAN CARLOS @ AbbVie Inc. - 2013-05-01

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
ALBAN CARLOS
2. Issuer Name and Ticker or Trading Symbol
AbbVie Inc. [ ABBV]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
X __ Officer (give title below) _____ Other (specify below)
EVP, Commercial Operations
(Last) (First) (Middle)
1 N. WAUKEGAN ROAD
3. Date of Earliest Transaction (MM/DD/YY)
05/01/2013
(Street)
NORTH CHICAGO, IL60064
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
__ X __ Form filed by One Reporting Person
_____ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common stock, $0.01 par value 05/01/2013 M 35,700 A $ 27.294 182,535 D
Common stock, $0.01 par value 05/01/2013 M 33,900 A $ 28.8628 216,435 D
Common stock, $0.01 par value 05/01/2013 M 17,700 A $ 28.1251 234,135 D
Common stock, $0.01 par value 05/01/2013 M 21,000 A $ 26.8472 255,135 D
Common stock, $0.01 par value 05/01/2013 M 34,600 A $ 28.3122 289,735 D
Common stock, $0.01 par value 05/01/2013 S 28,122 D $ 45.6837 261,613 D
Common stock, $0.01 par value 05/01/2013 S 27,320 D $ 45.6648 234,293 D
Common stock, $0.01 par value 05/01/2013 S 30,550 D $ 45.6768 203,743 D
Common stock, $0.01 par value 05/01/2013 S 27,664 D $ 45.6797 176,079 D
Common stock, $0.01 par value 40,442 ( 1 ) I Maria Cristina Alban 2007 Declaration of Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Option (right to buy) ( 2 ) $ 27.294 05/01/2013 M 35,700 02/16/2010 02/15/2017 Common stock 35,700 $ 0 0 D
Option (right to buy) ( 2 ) $ 28.8628 05/01/2013 M 33,900 02/15/2011 02/14/2018 Common stock 33,900 $ 0 0 D
Option (right to buy) ( 2 ) $ 28.1251 05/01/2013 M 17,700 02/20/2012 02/19/2019 Common stock 17,700 $ 0 0 D
Option (right to buy) ( 2 ) $ 26.8472 05/01/2013 M 21,000 10/15/2012 10/14/2019 Common stock 21,000 $ 0 0 D
Option (right to buy) ( 2 ) $ 28.3122 05/01/2013 M 34,600 02/19/2013 02/18/2020 Common stock 34,600 $ 0 0 D
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
ALBAN CARLOS
1 N. WAUKEGAN ROAD
NORTH CHICAGO, IL60064
EVP, Commercial Operations
Signatures
Steven L. Scrogham, attorney-in-fact for Carlos Alban 05/03/2013
Signature of Reporting Person Date
Explanation of Responses:
( 1 )Held in the Maria Christina Alban 2007 Declaration of Trust. The reporting person's spouse is trustee of the trust. The trust is revocable by his spouse. The reporting person disclaims beneficial ownership of these securities.
( 2 )Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

Remarks:
These exercises were made pursuant to a previously adopted plan complying with Rule 10b5-1(c ).

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.